Clinical Trials Logo

Burns clinical trials

View clinical trials related to Burns.

Filter by:

NCT ID: NCT02092701 Completed - Burn Injury Clinical Trials

Effects of Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period

Start date: October 2012
Phase: N/A
Study type: Interventional

Vitamin D has pleiotropic effects. Burn patients are at risk of hypovitaminosis D and may experience post-injury osteopenia and sarcopenia. Investigators hypothesized that vitamin D supplementation during one year can improve bone and muscle health in post-burn period.

NCT ID: NCT02088814 Completed - Burns Clinical Trials

Prevention of Posttraumatic Stress Symptoms in Young Children With Burns: a Randomized Controlled Trial

EPICAP
Start date: April 2014
Phase: N/A
Study type: Interventional

Background: Previous studies have found considerable rates of posttraumatic stress disorder (PTSD) or clinically relevant posttraumatic stress symptoms (PTSS) in preschoolers with injuries following accidental trauma. In consequence, secondary preventive efforts (early interventions) should be undertaken to minimize such long-term deleterious consequences in children. Aims: The proposed study aims at examining the effect of a newly developed, standardized early psychological intervention in reducing posttraumatic maladjustment and in enhancing health-related quality of life in children ages 1 to 4 years with acute burn injuries. Method: The study is designed as a randomized controlled trial within a stepped procedure. First, eligible children will be screened 5 to 7 days post injury by means of a standardized measure for their risk of developing PTSS. After a baseline assessment, children at risk will then be randomly allocated to either a control group (standard medical care) or an intervention group. Participants of the intervention group will be provided with the standardized "EPICAP 1-4" intervention which uses established cognitive-behavioral techniques and is directed to the parents. The intervention consists of two face-to-face sessions (at baseline and 1 week later) and a follow-up call or short follow-up face-to-face meeting (6 weeks after the first session). Blinded follow- up assessments with standardized parent report measures will be conducted at 3 and 6 months post injury. The primary outcome measures are child PTSD and PTSS, secondary outcome measures include child behavior and health-related quality of life. In addition, a variety of socio-demographic, medical and parental variables will be assessed as co-variates. Children screened as low-risk will be reassessed only at 6 months to make sure that the screening procedure is valid.

NCT ID: NCT02078128 Completed - Burns Clinical Trials

To Study the Effect of β-glucans on Wound Healing

Start date: July 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect of β-glucans on wound healing.

NCT ID: NCT02068534 Completed - Suicide Clinical Trials

A Qualitative and Quantitative Analysis on the Living History of Survivors From Charcoal-burning Suicide

Start date: January 2014
Phase:
Study type: Observational

The current study aims to explore the risk factors, protective factors, resilient factors, and factors jeopardizing the recovery progress on survivors from charcoal-burning suicide. To this end, an in-depth individual interview and Mini-Mental State Examination(MMSE) will be used to acquire the first-hand information on the attempters. As well, a more comprehensive neuropsychological test, WAIS III, will be administered at 3-month, 6-month, and 12-month after the index suicide attempt.

NCT ID: NCT02059902 Completed - Thermal Burns Clinical Trials

Continuous Lidocaine Infusion for Management of Perioperative Burn Pain

Start date: September 2012
Phase: Phase 4
Study type: Interventional

Thermal injury results in one of the most intense and prolonged forms of pain the body can experience. Opioid narcotics are the most powerful drugs for acute and chronic pain, and their use in the perioperative period has been the mainstay of treatment; although medication requirements in burn patients are often underestimated. More medication may not be the answer, as relatively large doses of short acting opioids in the operative theater are associated with greater postoperative opioid consumption and higher pain scores. Furthermore, extensive use of opioids has resulted in the development of by hyperalgesia and allodynia. Lidocaine is an amide local anesthetic that has analgesic, anti-hyperalgesic, antiarrhythmic, and anti-inflammatory properties. Over the past 25 years, systemic lidocaine has been used for perioperative pain management in a variety of surgical procedures. The design of this study will examine if lidocaine will reduce the pain scores and narcotic utilization in patients undergoing surgical procedures for burn injuries. The intervention group will receive a bolus dose of lidocaine followed by a continuous infusion over 24 hours. The control group will get an equal volume of saline. The investigators will compare pain scores, opioid use, and narcotic equivalents based on body weight and burn surface area (BSA) grafted.

NCT ID: NCT02028520 Completed - Clinical trials for Predictors of Burn Wound Healing

Indocyanine Green (ICG) and SPY Imaging for Assessment of Burn Healing

Start date: January 2014
Phase: N/A
Study type: Interventional

Hypothesis: Higher levels of perfusion on indocyanine green (ICG) fluoroscopy indicate higher likelihood of burns healing whole lower levels of perfusion correlate with lower likelihood of healing Consented patients with burn injuries will be evaluated daily and along with continued wound care will receive 5 mg of ICG (FDA approved dose) and their burns assessed fluoroscopically. Perfusion will be quantified numerically as a percentage of normally perfused skin. No changes to the actual care of the burn patient will be made as a result of the fluoroscopic examination.

NCT ID: NCT02014298 Completed - Burn Scars Clinical Trials

Non Ablative Fractional Laser Treatment of Burn Scars

Start date: January 2012
Phase: N/A
Study type: Interventional

BACKGROUND: Increasing evidence appears for non-ablative fractional laser (NAFL) to remodel mature burn scars. OBJECTIVES: To investigate long-term clinical and histological appearance of mature burn scars after NAFL-treatment. HYPOTHESIS: That NAFL can modulate mature burn scars with subsequently improved cosmetic and functional appearance. METHODS: Study patients with burn scars at trunk or extremities. Side-by-side test areas are randomized to three monthly 1,540 nm NAFL-treatments or control, followed by blinded evaluations at 1, 3, and 6 months using mPOSAS (modified Patient and Observer Scar Assessment Scale; 1 = normal skin, 10 = worst imaginable scar).

NCT ID: NCT02012569 Completed - Burns Clinical Trials

Determine the Haemostatic Efficacy of TT-173, Reducing the Bleeding Time in the Donor Site of Skin Grafting

EHTIC
Start date: November 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the haemostatic efficacy of TT-173, reducing the bleeding time in the donor site of skin grafting.

NCT ID: NCT01983280 Completed - Burn Clinical Trials

The Effect of Healing Touch on Sleep Patterns of Pediatric Burn Patients

Sleep5
Start date: October 2009
Phase: N/A
Study type: Interventional

Adequate sleep is an important aspect of any healing process, and because it is known that children recovering from burns suffer long term sleep disruptions, the investigators believe that Healing Touch may improve the quality and quantity of sleep in the pediatric burn population.

NCT ID: NCT01939613 Completed - Burn Clinical Trials

Colloid Improves Organs Function in Resuscitation of Extensive Burn Patients

Start date: July 2010
Phase: N/A
Study type: Observational [Patient Registry]

The present study was to evaluate the effectiveness of colloid compared with crystalloids for fluid resuscitation in critical burn patients with total burn surface area ≥50%.